Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;14(5):269-278.
doi: 10.1038/nrrheum.2018.41. Epub 2018 Apr 12.

Classification of myositis

Ingrid E Lundberg  1   2 , Marianne de Visser  3 , Victoria P Werth  4
Affiliations
Review

Classification of myositis

Ingrid E Lundberg et al. Nat Rev Rheumatol. 2018 May.

Abstract

The idiopathic inflammatory myopathies (IIMs; also known as myositis) are a heterogeneous group of disorders in which a common feature is chronic inflammation of skeletal muscle, leading to muscle weakness. Other organs are frequently affected in IIMs, such as the skin, joints, lungs, gastrointestinal tract and heart, contributing to morbidity and mortality. Currently, IIMs are most often subclassified into polymyositis, dermatomyositis and inclusion body myositis, but this subclassification has limitations as these subgroups often have overlapping clinical and histopathological features, and outcomes vary within the subgroups; additionally, subgroups without considerable myopathy are not included. A new way of subgrouping patients could be on the basis of the presence of myositis-specific autoantibodies. These autoantibodies are associated with distinct clinical features and, moreover, can help to identify subsets of IIMs in which extramuscular symptoms, such as skin manifestations, arthritis or interstitial lung disease, might be the presenting or predominant feature when muscle symptoms are mild or absent. The recognition that subphenotypes with single-organ involvement other than muscles exist is important for identifying patients with early disease, for clinical care demanding team management and in designing clinical studies to improve our understanding of this heterogeneous disease to develop new therapies.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1240-6 - PubMed
    1. J Am Acad Dermatol. 2006 Apr;54(4):597-613 - PubMed
    1. N Engl J Med. 1975 Feb 13;292(7):344-7 - PubMed
    1. N Engl J Med. 1991 Nov 21;325(21):1487-98 - PubMed
    1. Acta Neuropathol Commun. 2014 Oct 23;2:154 - PubMed

Publication types

LinkOut - more resources